Garde Capital, Inc. Novo Nordisk A S Transaction History

Garde Capital, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 03, 2025	BUY	$58.08 - $81.05 $19,456 - $27,151	335 Added 39.41%	1,185 $81,000
Q1 2025 Apr 22, 2025	BUY	$69.3 - $90.95 $58,905 - $77,307	850 New	850 $59,000
Q2 2024 Aug 19, 2024	SELL	$122.71 - $146.91 $22,333 - $26,737	-182 Reduced 16.71%	907 $129,000
Q1 2024 May 29, 2024	BUY	$102.11 - $135.92 $111,197 - $148,016	1,089 New	1,089 $139,000

1,689

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Garde Capital, Inc. with notifications on news.